EHI
ALNY icon

Eagle Health Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Eagle Health Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,686
Closed -$10.8M – 33
2025
Q3 		$10.8M Sell
23,686
-22,400
-49% -$9.12M 2.84% 14
2025
Q2 		$15M Sell
46,086
-19,570
-30% -$5.42M 3.71% 12
2025
Q1 		$17.7M Sell
65,656
-10,600
-14% -$2.72M 4.6% 10
2024
Q4 		$17.9M Hold
76,256
– – 4.4% 12
2024
Q3 		$21M Hold
76,256
– – 3.97% 12
2024
Q2 		$18.5M Buy
76,256
+27,900
+58% +$4.4M 3.25% 14
2024
Q1 		$7.23M Sell
48,356
-88,400
-65% -$14.7M 1.34% 22
2023
Q4 		$26.2M Hold
136,756
– – 5.32% 9
2023
Q3 		$24.2M Hold
136,756
– – 5.34% 9
2023
Q2 		$26M Hold
136,756
– – 4.86% 9
2023
Q1 		$27.4M Sell
136,756
-18,960
-12% -$3.99M 5.33% 8
2022
Q4 		$37M Sell
155,716
-6,000
-4% -$1.28M 8.54% 2
2022
Q3 		$32.4M Buy
161,716
+12,336
+8% +$2.35M 7.43% 3
2022
Q2 		$21.8M Buy
149,380
+18,136
+14% +$2.57M 5.08% 8
2022
Q1 		$21.4M Buy
131,244
+17,542
+15% +$2.67M 5.28% 8
2021
Q4 		$19.3M Buy
113,702
+23,600
+26% +$4.39M 4.7% 9
2021
Q3 		$17M Sell
90,102
-18,077
-17% -$3.39M 5.4% 7
2021
Q2 		$18.3M Hold
108,179
– – 6.29% 5
2021
Q1 		$15.3M Buy
108,179
+22,386
+26% +$3.37M 6% 8
2020
Q4 		$11.2M Buy
+85,793
New +$11.5M 7.13% 6

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Eagle Health Investments's ALNY Position: Q4 2025 in Review

Eagle Health Investments sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2025, closing a stake of 23,686 shares — an estimated $10.8M sold.

Eagle Health Investments first reported a position in ALNY in Q4 2020 and held it in 20 quarters. The position peaked at $37M in Q4 2022. 851 funds tracked by Wall St. Rank hold ALNY as of Q4 2025.

  • Eagle Health Investments reported no remaining Alnylam Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Eagle Health Investments sold 23,686 Alnylam Pharmaceuticals shares in Q4 2025, an estimated $10.8M.
  • Eagle Health Investments first reported a position in Alnylam Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Eagle Health Investments's Alnylam Pharmaceuticals position peaked at $37M in Q4 2022.
  • 851 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2025.

Based on Eagle Health Investments's 13F filing for Q4 2025, filed 6 Feb 2026.